HEADER FLAVOPROTEIN 23-AUG-06 2I51 TITLE CRYSTAL STRUCTURE OF A PYRIDOXAMINE 5'-PHOSPHATE OXIDASE-RELATED, FMN TITLE 2 BINDING PROTEIN (NPUN_F5749) FROM NOSTOC PUNCTIFORME PCC 73102 AT TITLE 3 1.40 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNCHARACTERIZED CONSERVED PROTEIN OF COG5135; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NOSTOC PUNCTIFORME; SOURCE 3 ORGANISM_TAXID: 63737; SOURCE 4 STRAIN: PCC 73102; SOURCE 5 GENE: ZP_00109616.1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS PYRIDOXAMINE 5'-PHOSPHATE OXIDASE-RELATED PROTEIN, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-2, FLAVOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 25-OCT-17 2I51 1 REMARK REVDAT 5 18-OCT-17 2I51 1 REMARK REVDAT 4 13-JUL-11 2I51 1 VERSN REVDAT 3 28-JUL-10 2I51 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 2I51 1 VERSN REVDAT 1 05-SEP-06 2I51 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN OF JRNL TITL 2 COG5135 (ZP_00109616.1) FROM NOSTOC PUNCTIFORME PCC 73102 AT JRNL TITL 3 1.40 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 96170 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.188 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4853 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6569 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.3230 REMARK 3 BIN FREE R VALUE SET COUNT : 318 REMARK 3 BIN FREE R VALUE : 0.3470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3120 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 148 REMARK 3 SOLVENT ATOMS : 359 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 15.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : 0.45000 REMARK 3 B33 (A**2) : -0.44000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.052 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.054 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.038 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.907 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.973 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.963 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3453 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2455 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4706 ; 1.637 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5908 ; 0.974 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 414 ; 5.541 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 174 ;36.686 ;22.989 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 519 ;12.160 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 36 ;15.905 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 480 ; 0.107 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3799 ; 0.012 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 717 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 631 ; 0.213 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2783 ; 0.227 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1636 ; 0.189 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1895 ; 0.086 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 288 ; 0.166 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 17 ; 0.310 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 46 ; 0.331 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.193 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2069 ; 2.135 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 768 ; 0.506 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3251 ; 3.065 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1684 ; 4.321 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1440 ; 6.091 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 194 REMARK 3 ORIGIN FOR THE GROUP (A): 48.0279 62.1066 4.2312 REMARK 3 T TENSOR REMARK 3 T11: -0.0376 T22: -0.0460 REMARK 3 T33: -0.0389 T12: 0.0012 REMARK 3 T13: -0.0072 T23: 0.0014 REMARK 3 L TENSOR REMARK 3 L11: 0.2245 L22: 0.5216 REMARK 3 L33: 1.0564 L12: 0.2098 REMARK 3 L13: 0.0872 L23: 0.3082 REMARK 3 S TENSOR REMARK 3 S11: -0.0455 S12: 0.0565 S13: 0.0301 REMARK 3 S21: -0.0911 S22: -0.0129 S23: 0.0541 REMARK 3 S31: -0.0817 S32: 0.0031 S33: 0.0585 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 0 B 194 REMARK 3 ORIGIN FOR THE GROUP (A): 47.2543 73.0979 24.3294 REMARK 3 T TENSOR REMARK 3 T11: -0.0276 T22: -0.0591 REMARK 3 T33: -0.0234 T12: -0.0009 REMARK 3 T13: 0.0093 T23: -0.0142 REMARK 3 L TENSOR REMARK 3 L11: 0.4849 L22: 0.6878 REMARK 3 L33: 1.1390 L12: 0.0901 REMARK 3 L13: 0.1257 L23: 0.4465 REMARK 3 S TENSOR REMARK 3 S11: -0.0204 S12: -0.0764 S13: 0.0620 REMARK 3 S21: 0.0024 S22: -0.0546 S23: 0.1077 REMARK 3 S31: -0.1309 S32: -0.0390 S33: 0.0750 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL REMARK 3 S-MET INCORPORATION. REMARK 3 3. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. REMARK 3 4. RESIDUES B134-137 ARE DISORDERED AND WERE NOT MODELED. REMARK 3 5. FMN MODELED BASED ON PROPOSED FUNCTION AND DENSITY. REMARK 3 6. ETHYLENE GLYCOL AND GLYCEROL MODELED BASED ON CRYSTALLIAZTION REMARK 3 CONDITIONS. REMARK 3 7. THERE IS UNMODELED DENSITY NEAR A45, A115, AND B153. REMARK 4 REMARK 4 2I51 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000039145. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUL-06; 02-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : NULL; NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : SSRL; SSRL REMARK 200 BEAMLINE : BL1-5; BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL; M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978489; 0.979264,0.911617 REMARK 200 MONOCHROMATOR : NULL; SINGLE CRYSTAL SI(111) REMARK 200 BENT MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : 1M LONG RH COATED BENT REMARK 200 CYLINDRICAL MIRROR FORHORIZONTAL REMARK 200 AND VERTICAL FOCUSSING; FLAT REMARK 200 MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315; ADSC QUANTUM REMARK 200 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 96246 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.397 REMARK 200 RESOLUTION RANGE LOW (A) : 29.386 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.11300 REMARK 200 R SYM (I) : 0.11300 REMARK 200 FOR THE DATA SET : 3.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.01000 REMARK 200 R SYM FOR SHELL (I) : 0.01016 REMARK 200 FOR SHELL : 0.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL; MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20.0% GLYCEROL, 24.0% PEG-1500, VAPOR REMARK 280 DIFFUSION,SITTING DROP,NANODROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.82350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.19000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.96400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.19000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.82350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.96400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY DATA SUPPORTS THE REMARK 300 ASSIGNMENT OF A DIMER AS A BIOLOGICALLY SIGNIFICANT REMARK 300 OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 ILE B 134 REMARK 465 LYS B 135 REMARK 465 GLU B 136 REMARK 465 SER B 137 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MSE A 1 CG SE CE REMARK 470 GLU A 49 CD OE1 OE2 REMARK 470 GLN A 69 CD OE1 NE2 REMARK 470 SER A 137 CB OG REMARK 470 GLU A 172 CD OE1 OE2 REMARK 470 GLN A 185 OE1 NE2 REMARK 470 GLU B 49 CD OE1 OE2 REMARK 470 ASP B 50 OD1 OD2 REMARK 470 GLN B 69 CD OE1 NE2 REMARK 470 ASP B 100 CG OD1 OD2 REMARK 470 LYS B 131 CE NZ REMARK 470 GLU B 141 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 84 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 72 45.85 -89.80 REMARK 500 SER A 97 -156.46 -113.12 REMARK 500 HIS A 102 59.48 -140.89 REMARK 500 PRO B 72 49.94 -88.05 REMARK 500 SER B 97 -156.29 -107.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN B 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 309 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 310 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 311 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 312 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 309 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 367231 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE REMARK 999 TARGET SEQUENCE. A SUITABLE DATABASE REFERENCE WAS NOT REMARK 999 AVAILABLE AT THE TIME OF PROCESSING. DBREF 2I51 A 1 181 UNP Q8YQ04 Q8YQ04_ANASP 1 181 DBREF 2I51 B 1 181 UNP Q8YQ04 Q8YQ04_ANASP 1 181 SEQRES 1 A 195 GLY MSE SER LEU ALA PRO TRP ARG GLY ALA ILE ALA HIS SEQRES 2 A 195 ALA LEU HIS ARG ASN ARG SER LEU VAL TYR ALA ARG TYR SEQRES 3 A 195 LEU GLN LEU ALA THR VAL GLN PRO ASN GLY ARG PRO ALA SEQRES 4 A 195 ASN ARG THR LEU VAL PHE ARG GLY PHE LEU GLU ASP THR SEQRES 5 A 195 ASN GLN LEU ARG PHE ILE THR ASP THR ARG SER ALA LYS SEQRES 6 A 195 ALA ASP GLN ILE GLN GLN GLN PRO TRP ALA GLU ILE CYS SEQRES 7 A 195 TRP TYR PHE PRO ASN THR ARG GLU GLN PHE ARG MSE ALA SEQRES 8 A 195 GLY ASP LEU THR LEU ILE SER SER ASP ASP SER HIS GLN SEQRES 9 A 195 ASP LEU GLN PRO ALA ARG ILE ALA MSE TRP GLN GLU LEU SEQRES 10 A 195 SER ASP ALA ALA ARG LEU GLN PHE GLY TRP PRO TYR PRO SEQRES 11 A 195 GLY LYS PRO ARG ILE LYS GLU SER GLY ALA PHE GLU PRO SEQRES 12 A 195 SER PRO PRO ASP PRO ILE GLU PRO VAL PRO ASN PHE CYS SEQRES 13 A 195 LEU LEU LEU LEU ASP PRO VAL GLN VAL ASP HIS LEU GLU SEQRES 14 A 195 LEU ARG GLY GLU PRO GLN ASN ARG TRP LEU TYR HIS ARG SEQRES 15 A 195 ASN ASP GLN GLN GLU TRP SER SER GLU ALA ILE ASN PRO SEQRES 1 B 195 GLY MSE SER LEU ALA PRO TRP ARG GLY ALA ILE ALA HIS SEQRES 2 B 195 ALA LEU HIS ARG ASN ARG SER LEU VAL TYR ALA ARG TYR SEQRES 3 B 195 LEU GLN LEU ALA THR VAL GLN PRO ASN GLY ARG PRO ALA SEQRES 4 B 195 ASN ARG THR LEU VAL PHE ARG GLY PHE LEU GLU ASP THR SEQRES 5 B 195 ASN GLN LEU ARG PHE ILE THR ASP THR ARG SER ALA LYS SEQRES 6 B 195 ALA ASP GLN ILE GLN GLN GLN PRO TRP ALA GLU ILE CYS SEQRES 7 B 195 TRP TYR PHE PRO ASN THR ARG GLU GLN PHE ARG MSE ALA SEQRES 8 B 195 GLY ASP LEU THR LEU ILE SER SER ASP ASP SER HIS GLN SEQRES 9 B 195 ASP LEU GLN PRO ALA ARG ILE ALA MSE TRP GLN GLU LEU SEQRES 10 B 195 SER ASP ALA ALA ARG LEU GLN PHE GLY TRP PRO TYR PRO SEQRES 11 B 195 GLY LYS PRO ARG ILE LYS GLU SER GLY ALA PHE GLU PRO SEQRES 12 B 195 SER PRO PRO ASP PRO ILE GLU PRO VAL PRO ASN PHE CYS SEQRES 13 B 195 LEU LEU LEU LEU ASP PRO VAL GLN VAL ASP HIS LEU GLU SEQRES 14 B 195 LEU ARG GLY GLU PRO GLN ASN ARG TRP LEU TYR HIS ARG SEQRES 15 B 195 ASN ASP GLN GLN GLU TRP SER SER GLU ALA ILE ASN PRO MODRES 2I51 MSE A 1 MET SELENOMETHIONINE MODRES 2I51 MSE A 89 MET SELENOMETHIONINE MODRES 2I51 MSE A 112 MET SELENOMETHIONINE MODRES 2I51 MSE B 1 MET SELENOMETHIONINE MODRES 2I51 MSE B 89 MET SELENOMETHIONINE MODRES 2I51 MSE B 112 MET SELENOMETHIONINE HET MSE A 1 5 HET MSE A 89 13 HET MSE A 112 8 HET MSE B 1 8 HET MSE B 89 13 HET MSE B 112 8 HET FMN A 300 31 HET EDO A 301 4 HET EDO A 302 4 HET EDO A 303 4 HET EDO A 304 4 HET EDO A 305 4 HET EDO A 306 4 HET EDO A 307 4 HET EDO A 308 4 HET EDO A 309 4 HET EDO A 310 4 HET EDO A 311 4 HET EDO A 312 4 HET FMN B 300 31 HET EDO B 301 4 HET EDO B 302 4 HET EDO B 303 6 HET EDO B 304 8 HET EDO B 305 4 HET EDO B 306 4 HET EDO B 307 4 HET EDO B 308 4 HET GOL B 309 6 HETNAM MSE SELENOMETHIONINE HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM EDO 1,2-ETHANEDIOL HETNAM GOL GLYCEROL HETSYN FMN RIBOFLAVIN MONOPHOSPHATE HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 FMN 2(C17 H21 N4 O9 P) FORMUL 4 EDO 20(C2 H6 O2) FORMUL 25 GOL C3 H8 O3 FORMUL 26 HOH *359(H2 O) HELIX 1 1 TRP A 6 ASN A 17 1 12 HELIX 2 2 LEU A 20 ALA A 23 5 4 HELIX 3 3 SER A 62 GLN A 71 1 10 HELIX 4 4 HIS A 102 ASP A 104 5 3 HELIX 5 5 LEU A 105 LEU A 116 1 12 HELIX 6 6 SER A 117 GLN A 123 1 7 HELIX 7 7 PHE A 124 TRP A 126 5 3 HELIX 8 8 GLU A 136 GLU A 141 5 6 HELIX 9 9 TRP B 6 ASN B 17 1 12 HELIX 10 10 LEU B 20 ALA B 23 5 4 HELIX 11 11 SER B 62 GLN B 71 1 10 HELIX 12 12 ASP B 99 ASP B 104 5 6 HELIX 13 13 LEU B 105 LEU B 116 1 12 HELIX 14 14 SER B 117 GLN B 123 1 7 HELIX 15 15 PHE B 124 TRP B 126 5 3 SHEET 1 A 6 PRO A 37 VAL A 43 0 SHEET 2 A 6 TYR A 25 VAL A 31 -1 N LEU A 28 O ARG A 40 SHEET 3 A 6 TRP A 73 PHE A 80 -1 O GLU A 75 N ALA A 29 SHEET 4 A 6 GLU A 85 ILE A 96 -1 O MSE A 89 N ILE A 76 SHEET 5 A 6 PHE A 154 GLU A 168 -1 O LEU A 156 N ILE A 96 SHEET 6 A 6 LEU A 54 ASP A 59 -1 N PHE A 56 O LEU A 157 SHEET 1 B 7 PRO A 37 VAL A 43 0 SHEET 2 B 7 TYR A 25 VAL A 31 -1 N LEU A 28 O ARG A 40 SHEET 3 B 7 TRP A 73 PHE A 80 -1 O GLU A 75 N ALA A 29 SHEET 4 B 7 GLU A 85 ILE A 96 -1 O MSE A 89 N ILE A 76 SHEET 5 B 7 PHE A 154 GLU A 168 -1 O LEU A 156 N ILE A 96 SHEET 6 B 7 ASN A 175 ARG A 181 -1 O ASN A 175 N GLU A 168 SHEET 7 B 7 TRP A 187 ALA A 191 -1 O GLU A 190 N LEU A 178 SHEET 1 C 6 PRO B 37 VAL B 43 0 SHEET 2 C 6 TYR B 25 VAL B 31 -1 N LEU B 28 O ARG B 40 SHEET 3 C 6 TRP B 73 PHE B 80 -1 O CYS B 77 N GLN B 27 SHEET 4 C 6 GLU B 85 ILE B 96 -1 O GLU B 85 N PHE B 80 SHEET 5 C 6 PHE B 154 GLU B 168 -1 O VAL B 162 N ALA B 90 SHEET 6 C 6 LEU B 54 ASP B 59 -1 N PHE B 56 O LEU B 157 SHEET 1 D 7 PRO B 37 VAL B 43 0 SHEET 2 D 7 TYR B 25 VAL B 31 -1 N LEU B 28 O ARG B 40 SHEET 3 D 7 TRP B 73 PHE B 80 -1 O CYS B 77 N GLN B 27 SHEET 4 D 7 GLU B 85 ILE B 96 -1 O GLU B 85 N PHE B 80 SHEET 5 D 7 PHE B 154 GLU B 168 -1 O VAL B 162 N ALA B 90 SHEET 6 D 7 ASN B 175 ARG B 181 -1 O ASN B 175 N GLU B 168 SHEET 7 D 7 TRP B 187 ALA B 191 -1 O GLU B 190 N LEU B 178 LINK C MSE A 1 N SER A 2 1555 1555 1.33 LINK C ARG A 88 N MSE A 89 1555 1555 1.31 LINK C MSE A 89 N ALA A 90 1555 1555 1.32 LINK C ALA A 111 N MSE A 112 1555 1555 1.34 LINK C MSE A 112 N TRP A 113 1555 1555 1.33 LINK C GLY B 0 N MSE B 1 1555 1555 1.34 LINK C MSE B 1 N SER B 2 1555 1555 1.33 LINK C ARG B 88 N MSE B 89 1555 1555 1.32 LINK C MSE B 89 N ALA B 90 1555 1555 1.33 LINK C ALA B 111 N MSE B 112 1555 1555 1.33 LINK C MSE B 112 N TRP B 113 1555 1555 1.34 CISPEP 1 GLU A 172 PRO A 173 0 5.32 CISPEP 2 GLU B 172 PRO B 173 0 2.08 SITE 1 AC1 23 TYR A 25 ARG A 40 THR A 41 LEU A 42 SITE 2 AC1 23 VAL A 43 ARG A 45 ILE A 57 THR A 58 SITE 3 AC1 23 SER A 62 ALA A 63 LYS A 64 EDO A 306 SITE 4 AC1 23 EDO A 307 HOH A 313 HOH A 341 HOH A 342 SITE 5 AC1 23 HOH A 374 HOH A 481 TYR B 79 GLN B 86 SITE 6 AC1 23 ARG B 88 EDO B 305 HOH B 320 SITE 1 AC2 22 TYR A 79 GLN A 86 ARG A 88 HOH A 394 SITE 2 AC2 22 TYR B 25 ARG B 40 THR B 41 LEU B 42 SITE 3 AC2 22 VAL B 43 ILE B 57 THR B 58 SER B 62 SITE 4 AC2 22 ALA B 63 LYS B 64 EDO B 301 EDO B 302 SITE 5 AC2 22 EDO B 306 HOH B 314 HOH B 343 HOH B 347 SITE 6 AC2 22 HOH B 477 HOH B 478 SITE 1 AC3 5 GLN A 174 GLN B 123 FMN B 300 EDO B 302 SITE 2 AC3 5 HOH B 456 SITE 1 AC4 5 GLN B 123 PHE B 124 FMN B 300 EDO B 301 SITE 2 AC4 5 HOH B 391 SITE 1 AC5 6 ASN A 82 ARG A 170 HOH A 369 HOH A 467 SITE 2 AC5 6 ASP B 146 HOH B 322 SITE 1 AC6 4 ALA A 111 GLN A 114 GLU A 115 GOL B 309 SITE 1 AC7 7 GLN A 32 HOH A 321 GLU B 75 ARG B 88 SITE 2 AC7 7 EDO B 304 HOH B 333 HOH B 353 SITE 1 AC8 9 GLU B 75 ARG B 88 MSE B 89 ALA B 90 SITE 2 AC8 9 GLN B 163 ASP B 165 LEU B 178 EDO B 303 SITE 3 AC8 9 HOH B 422 SITE 1 AC9 4 MSE A 1 LEU A 3 ASP A 50 THR A 51 SITE 1 BC1 7 SER A 62 ALA A 63 PRO A 129 GLY A 130 SITE 2 BC1 7 FMN A 300 ARG B 176 HOH B 451 SITE 1 BC2 6 GLU A 75 ARG A 88 ALA A 90 GLN A 163 SITE 2 BC2 6 ASP A 165 HOH A 390 SITE 1 BC3 6 MSE A 1 ASN A 52 ARG A 181 GLN A 185 SITE 2 BC3 6 HOH A 349 HOH A 368 SITE 1 BC4 7 ILE A 57 GLN A 123 PHE A 124 FMN A 300 SITE 2 BC4 7 HOH A 354 HOH A 401 HOH A 481 SITE 1 BC5 5 GLN A 123 FMN A 300 HOH A 482 GLN B 174 SITE 2 BC5 5 HOH B 365 SITE 1 BC6 6 ASP A 100 SER A 101 HIS A 102 GLN A 103 SITE 2 BC6 6 ASP A 104 HOH A 459 SITE 1 BC7 7 PRO A 72 LEU A 93 THR A 94 LEU A 95 SITE 2 BC7 7 HIS A 102 HOH A 426 HOH A 474 SITE 1 BC8 8 ARG A 176 HOH A 457 SER B 62 ALA B 63 SITE 2 BC8 8 PRO B 129 GLY B 130 FMN B 300 HOH B 488 SITE 1 BC9 6 SER A 98 ASP A 99 GLN A 103 ARG B 121 SITE 2 BC9 6 HOH B 312 HOH B 450 SITE 1 CC1 6 MSE B 1 LEU B 3 ASP B 50 THR B 51 SITE 2 CC1 6 ASN B 52 HOH B 328 SITE 1 CC2 2 ASN B 34 HOH B 481 SITE 1 CC3 6 THR A 60 ARG A 61 SER A 62 ALA A 63 SITE 2 CC3 6 ALA A 65 ASP A 66 SITE 1 CC4 6 GLU A 75 ARG A 88 HOH A 488 GLN B 32 SITE 2 CC4 6 ALA B 38 HOH B 330 SITE 1 CC5 6 PRO A 107 GLN A 114 EDO A 302 GLN B 114 SITE 2 CC5 6 HOH B 334 HOH B 447 CRYST1 65.647 65.928 112.380 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015230 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015170 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008900 0.00000 HETATM 1 N MSE A 1 61.015 62.566 -8.836 1.00 49.89 N HETATM 2 CA MSE A 1 61.534 61.370 -9.576 1.00 48.25 C HETATM 3 C MSE A 1 62.760 60.801 -8.866 1.00 45.22 C HETATM 4 O MSE A 1 62.878 59.581 -8.707 1.00 50.28 O HETATM 5 CB MSE A 1 61.867 61.704 -11.035 1.00 49.10 C